Samra Turajlic M.D. Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of kidney cancer and melanoma Discusses Sensitivity Of cfDNA Method. At The Fourteenth European International Kidney Cancer Symposium on Mar 29, 2019
